WeVote
Log In

Bill

Bill

H 2377

An Act to improve patient access to prescription medication

194th Legislature (2025-2026) Introduced by Nick Boldyga

Massachusetts bill H 2377 expands patient access to prescription medications through measures under Public Health Committee review, aiming to improve medication affordability and availability statewide.

Accompanied a study order, see H5234
0
WeVote Research Nonpartisan
Bill Summary · H 2377

Legislative bill overview

H 2377 aims to improve patient access to prescription medications in Massachusetts, though the bill's specific mechanisms are not detailed in the provided legislative history. The measure was introduced by Rep. Nick Boldyga and is currently under review by the Public Health Committee, with a reporting deadline extended to October 9, 2025.

Why is this important

Prescription medication access is a significant healthcare equity issue affecting affordability, health outcomes, and medication adherence across Massachusetts. Improvements to access could reduce treatment delays, lower emergency room visits, and decrease overall healthcare costs, particularly for vulnerable populations.

Potential points of contention

  • Cost implications: Changes to medication access policies may shift costs between insurers, employers, patients, and pharmaceutical manufacturers, creating disagreement over who bears financial responsibility
  • Insurance market effects: Increased access mandates could influence insurance premium rates and coverage policies, with concerns from insurers about regulatory burden
  • Implementation complexity: Healthcare systems, pharmacies, and insurers may face operational challenges implementing new access requirements without clear standards or funding mechanisms

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.